Introduction
Glutathione, an important modulator of the cellular redox environment, is found in blood where it could modulate the redox environment of platelets. Cells contain millimolar concentrations of glutathione, mostly in the reduced form. Plasma contains only 8 to 25 M glutathione, [1] [2] [3] [4] [5] [6] also predominantly in the reduced form. This contrasts with other low-molecular-weight thiols that are mostly in disulfide forms. 2, 6 Plasma glutathione levels and GSH/ glutathione disulfide (GSSG) ratios in plasma are altered in disease states. 4, 5, 7 However, little is known about the role of plasma glutathione in the regulation of redox reactions. We recently found that physiologic concentrations of GSH generate thiols from disulfide bonds in ␣ IIb ␤ 3 and potentiate platelet aggregation. 7 Recent reports have also raised the possibility that platelets have a transplasma membrane oxidoreductase that, like GSH, can reduce extracellular disulfide bonds in redox-sensitive membrane proteins. [7] [8] [9] Although there is little information about such systems in cells, a form of a cell membrane nicotinamide adenine dinucleotide (NADH) oxidase 10, 11 in plant cells has been reported to have disulfide reductase activity. 12 Cells and platelets contain flavoprotein-electron transport systems such as nicotinamide adenine dinucleotide phosphate (NADPH) oxidase on neutrophils; however, the electron acceptor is molecular oxygen (not disulfide bonds) and the product is superoxide anion (O 2 Ϫ ). [13] [14] [15] There are no reports of transplasma membrane electron transport systems that reduce disulfide bonds in mammalian cells. We here report that nonstimulated platelets have the ability to reduce the disulfide bond in extracellular GSSG. This results in the production of GSH, the generation of thiols in the ␣ IIb ␤ 3 integrin, and the facilitation of platelet aggregation.
Study design
Platelet aggregation, measurement of extracellular sulfhydryls in platelet samples, and sulfhydryl labeling of extracellular of platelets were performed as described elsewhere. 7
Results and discussion
We previously found that GSH or a mixture of GSH/GSSG potentiated platelet aggregation stimulated by agonists such as collagen. 7 When GSSG (5 M) was used alone as a control for the collagen-induced aggregation studies, surprisingly, it also enhanced platelet aggregation ( Figure 1 ). As expected, GSSG alone did not contain any GSH by the 5,5Ј-dithiobis-(2-nitrobenzoid) acid (DTNB) assay (not shown). When the concentration of agonist gave partial or submaximal aggregation, a low concentration of GSSG (2 M) further stimulated aggregation ( Figure 1B) . Thus, under appropriate conditions low concentrations of glutathione, similar to those found in blood, substantially potentiate aggregation.
We hypothesized that the GSSG was being converted to GSH by the platelets. To test this we incubated GSSG with gel-filtered platelets and measured total thiols in the sample. The combination of GSSG with platelets gave substantially more free thiols as detected by DTNB than could be accounted for by either platelets or GSSG alone ( Figure 1C ). The amount of sulfhydryls on platelets alone corresponded to about 9.0 ϫ 10 Ϫ18 mol thiol/platelet (similar to what has been reported). 16, 17 Platelets with GSH (10 M) gave the additive results of platelets alone plus GSH alone (column 3). Platelets with GSSG (5 M) gave about double what was expected from platelets alone (about 6.5 M additional SH; P Ͻ .05; n ϭ 5). This suggests that 3 to 4 M of the GSSG added is being converted to GSH by platelets. Therefore, the addition of GSSG to platelets would result in a ratio of GSH/GSSG of approximately 3:1 to 4:1. This ratio is similar to that found in blood and to the GSH/GSSG ratio that provides maximal potentiation of platelet activation. 7 In contrast to the effect of platelets on GSSG, when cystine (the disulfide form of cysteine) was incubated with platelets no increase in sulfhydryls was found ( Figure 1D ). This indicates some specificity of the reaction.
The conversion of GSSG to GSH requires the addition of 2 electrons to reduce the disulfide bond. In cells NADPH serves as the electron donor for GSSG in the following reaction: GSSG ϩ NADPH ϩ H ϩ 3 2 GSH ϩ NADP ϩ . Therefore, the generation of GSH by platelets in the absence of external reducing agents implicates a transmembrane electron transport system that uses a cytoplasmic electron donor, presumably NAD(P)H. NADPH oxidase 13, 14 and NADH oxidase [10] [11] [12] 18, 19 are plasma membrane oxidoreductase systems found in cells. To begin to explore these possibilities, we tested the effect of diphenyleneiodonium (DPI), an inhibitor of flavin-containing enzymes, as well as a structurally unrelated inhibitor of NADPH oxidase, apocynin. 20 Both DPI (10 M) and apocynin inhibited the GSSG reductase activity ( Figure  1E ). Because the reaction is inhibited by relatively low concentrations of DPI, the mechanism likely involves a flavoprotein.
Time-course studies on the conversion of GSSG to GSH were performed at 37°C, the conditions under which GSSG enhanced platelet aggregation. The platelet reaction with GSSG was complete by 1 minute (Figure 2A ). This suggests that the effect of GSSG on platelet aggregation occurs after some GSSG is converted to GSH, and thus after an appropriate redox potential for platelet activation is reached. To test for this possibility we compared the effect of GSSG added 1 minute before collagen to GSSG added simultaneously with collagen. Figure 2B shows that GSSG (5 M) added simultaneously with collagen did not potentiate aggregation (the 0-second tracing). In contrast to the lack of effect of GSSG added with collagen, GSSG incubated for 1 minute with platelets as expected facilitated aggregation (the 60-second tracing). As expected from previous studies, 7 controls of GSH (10 M) or a mixture of GSH (10 M) and GSSG (2 M) potentiated aggregation when added simultaneously with collagen (not shown). These results imply that platelets convert GSSG to GSH and this can be part of the stimulus for platelet activation.
The effect of GSH (10 M) and GSSG (5 M) on sulfhydryl generation in ␣ IIb ␤ 3 is shown in Figure 2C . Using immunoprecipitation the bands shown were previously identified as ␣ IIb and ␤ 3 . 7 GSH, previously found to generate sulfhydryls in the ␤ 3 subunit, Figure 2 . Time-course studies on GSSG and platelets and the effect of GSSG on sulfhydryl labeling of ␣IIb␤3. (A) Time course of GSSG conversion to GSH at 37°C. In these studies GSSG was added to platelets for the indicated times, and then DTNB was added. Total SH in the sample was measured as described for Figure 1C Densitometry of the individual bands was used to obtain quantitative results. The first 2 columns show the ratio of labeling of the ␤ 3 subunit with GSH or GSSG to the ␤ 3 subunit without GSH (Ϯ 1 SE, n ϭ 8). As a control for possible translocation of ␣IIb␤3 the third and fourth columns give the ratio of labeling using a label for primary amines, sulfosuccinimido-biotin (SSB) in the ␤3 subunit with GSH or GSSG to the ␤3 subunit without GSH (Ϯ 1 SE). These experiments were performed 3 times with similar results. (C-E) Gel-filtered platelets were incubated with GSSG, or under other conditions, and total sulfhydryl (SH) content in the sample was determined using DTNB as described. 7 (C) Results of platelets incubated with GSSG. Platelets alone are in column 1. Column 2 shows the results of platelets preincubated with GSSG (5 M) for 15 minutes at 24°C before the DTNB was added. Column 3 shows the results for GSH (10 M) with platelets (Plat/GSH). For these experiments, n ϭ 5. (D) The lack of effect of platelets on cystine (disulfide of cysteine) is seen. Column 1 again shows the amount of SH in platelets. Column 2 shows the SH content of platelets incubated with 5 M cystine (Plat/cystine). Also shown are platelets with cysteine (10 M; Plat/cysteine). For these experiments, n ϭ 7. (E) The effect of NADPH oxidase inhibitors on conversion of GSSG to GSH is seen. The first column shows the SH content of platelets. Column 2 is the SH content of the platelet/GSSG mixture; columns 3 and 4 are the same as column 2 except that the flavoprotein NADPH oxidase inhibitors DPI (10 M) or apocynin (100 M; Apo) were added to the platelets for 30 minutes prior to the addition of GSSG. For these experiments, n ϭ 2 to 4 for each sample. The results are Ϯ 1 SE.
increased sulfhydryl labeling in ␤ 3 by 2-2.5 fold. A concentration of GSSG (5 M) that potentiated platelet aggregation increased sulfhydryl labeling in the ␤ 3 subunit by almost 3-fold ( Figure 2D ). This is similar to the effect of GSH (10 M) and confirms a mechanism in ␣ IIb ␤ 3 . A 1.6-to 1.7-fold increase in labeling of ␣ IIb was also found with both GSH and GSSG (not shown). Because GSH by itself does not cause platelet aggregation, 7 the sulfhydryl generation in ␤ 3 apparently does not by itself activate the receptor. An additional stimulus is necessary.
In summary, the conversion of GSSG to GSH by platelets implicates a novel surface flavoprotein GSH reductase activity that may be a marker for a more general disulfide reductase activity. This activity appears to provide the appropriate redox potential for platelet activation. This reaction may modulate the local redox environment at sites of vascular injury where platelets are found in high concentrations. Redox-sensitive protein on platelets whose function may be modulated by the redox environment include ␣ IIb ␤ 3 and protein disulfide isomerase. 21 
